HC Wainwright & Co. Maintains Buy on Compass Pathways, Lowers Price Target to $65
COMPASS Pathways Plc Sponsored ADR
COMPASS Pathways Plc Sponsored ADR CMPS | 0.00 |
HC Wainwright & Co. analyst Patrick R. Trucchio maintains Compass Pathways (NASDAQ:
CMPS) with a Buy and lowers the price target from $70 to $65.
